CD8+T cell response to polycomb protein EZH2 in haemopoietic malignancies

被引：0
|
作者：
Kalk, E
Piper, K
Pratt, G
Young, L
Steele, J
Moss, P
机构：
[1] Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England
[2] Univ Birmingham, CR UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
来源：
IMMUNOLOGY | 2005年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] Decoding Immunodominance of an Antiviral CD8+T Cell Response
    Kotturi, Maya
    Scott, Iain
    Wolfe, Tom
    Peters, Bjoern
    Sidney, John
    von Herrath, Matthias G.
    Buchmeier, Michael J.
    Grey, Howard
    Sette, Alessandro
    FASEB JOURNAL, 2008, 22
  • [22] Erratum: The Polycomb group protein EZH2 directly controls DNA methylation
    Emmanuelle Viré
    Carmen Brenner
    Rachel Deplus
    Loïc Blanchon
    Mario Fraga
    Céline Didelot
    Lluis Morey
    Aleyde Van Eynde
    David Bernard
    Jean-Marie Vanderwinden
    Mathieu Bollen
    Manel Esteller
    Luciano Di Croce
    Yvan de Launoit
    François Fuks
    Nature, 2007, 446 : 824 - 824
  • [23] Kinetic evolution of a diabetogenic CD8+T cell response
    Santamaria, P
    IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN, 2003, 1005 : 88 - 97
  • [24] Characterization of the CD8+T cell response in rickettsial infections
    Gomez, Erika Caro
    Cespedes, Maria
    Texeira, Bruno
    Gazi, Michal
    Valbuena, Gustavo
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [25] Repression of E-cadherin by the polycomb group protein EZH2 in cancer
    Q Cao
    J Yu
    S M Dhanasekaran
    J H Kim
    R-S Mani
    S A Tomlins
    R Mehra
    B Laxman
    X Cao
    J Yu
    C G Kleer
    S Varambally
    A M Chinnaiyan
    Oncogene, 2008, 27 : 7274 - 7284
  • [26] Defects in the CD8+T cell response to arthritogenic alphaviruses
    Bullock, Christopher B.
    Davenport, Bennett J.
    Morrison, Thomas E.
    Miller, Mark J.
    Diamond, Michael S.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [27] The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
    Li, Zhongwu
    Wang, Yanling
    Qiu, Jing
    Li, Qiang
    Yuan, Chunping
    Zhang, Wei
    Wang, Dongmiao
    Ye, Jinhai
    Jiang, Hongbin
    Yang, Jianrong
    Cheng, Jie
    ONCOTARGET, 2013, 4 (12) : 2532 - 2549
  • [28] The polycomb group protein EZH2 is required for mammalian circadian clock function
    Etchegaray, Jean-Pierre
    Yang, Xiaoming
    DeBruyne, Jason P.
    Peters, Antoine H. F. M.
    Weaver, David R.
    Jenuwein, Thomas
    Reppert, Steven M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (30) : 21209 - 21215
  • [29] Eradication of Chronic Myelogenous Leukemia By Inactivation of the Polycomb Group Protein EZH2
    Xie, Huafeng
    Peng, Cong
    Qi, Jun
    Cheloni, Giullia
    Das, Partha
    Huang, Jialiang
    Minh Nguyen
    Li, Shaoguang
    Bradner, James E.
    Orkin, Stuart H.
    BLOOD, 2014, 124 (21)
  • [30] Repression of E-cadherin by the polycomb group protein EZH2 in cancer
    Cao, Q.
    Yu, J.
    Dhanasekaran, S. M.
    Kim, J. H.
    Mani, R-S
    Tomlins, S. A.
    Mehra, R.
    Laxman, B.
    Cao, X.
    Yu, J.
    Kleer, C. G.
    Varambally, S.
    Chinnaiyan, A. M.
    ONCOGENE, 2008, 27 (58) : 7274 - 7284
12345